Clinical trial
Study of Etanercept for the Prevention of Complications Resulting From…
NCT00141739 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00141739 |
|---|---|
| Title | Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) |
| Official title | The Addition of Etanercept to Standard GVHD Prophylaxis in Patients Undergoing a Full Intensity Allogeneic Hematopoietic Stem Cell Transplant for the Prevention of Transplant Related Complications |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft-Versus-Host Disease |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 100 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2011 |
| Completion | Sep 1, 2012 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: